QuickLogic Raises Approximately $3.2 Million with Strategic Investment by Institutional Investors
SAN JOSE, Calif., Sept. 20, 2022 -- QuickLogic Corporation (NASDAQ: QUIK) ("QuickLogic" or the "Company"), a developer of ultra-low power multi-core voice enabled SoCs, embedded FPGA IP, and Endpoint AI solutions, today announced current institutional investors have purchased 487,279 registered shares, or about 3.9 percent of the shares outstanding as of September 14, 2022, raising gross proceeds of approximately $3.2 million, at a price for each share of $6.57, in a registered direct offering. The offering was made without an underwriter or placement agent.
"We are fortunate to have the continued financial support from long-time shareholders that understand the tremendous opportunity in front of us to build upon our 30-years of expertise in delivering FPGA technology," said Brian Faith president and CEO of QuickLogic. "Their offer to invest in QuickLogic amidst challenging market conditions is invaluable and will enable us to execute on our nearly $100 million sales funnel as we drive the business to profitability."
A shelf registration statement was previously filed with the Securities and Exchange Commission ("SEC") and is effective. A prospectus supplement and accompanying prospectus describing the terms of the registered direct offering will be filed with the SEC. Copies of the prospectus supplement and the accompanying prospectus relating to the shares to be issued in the registered direct offering may be obtained for free by visiting the SEC's website at www.sec.gov.
This press release does not constitute an offer to sell or a solicitation of an offer to buy the securities in the offering, nor will there be any sale of these securities in any jurisdiction in which an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.
About QuickLogic
QuickLogic is a fabless semiconductor company that develops low power, multi-core semiconductor platforms and Intellectual Property (IP) for Artificial Intelligence (AI), voice and sensor processing. The solutions include an embedded FPGA IP (eFPGA) for hardware acceleration and pre-processing, and heterogeneous multi-core SoCs that integrate eFPGA with other processors and peripherals. The Analytics Toolkit from the Company's wholly owned subsidiary, SensiML Corporation, completes the end-to-end solution with accurate sensor algorithms using AI technology. The full range of platforms, software tools and eFPGA IP enables the practical and efficient adoption of AI, voice and sensor processing across the multitude of mobile, wearable, hearable, consumer, industrial, edge and endpoint IoT applications. For more information, visit www.quicklogic.com and https://www.quicklogic.com/blog/.
|
QuickLogic Corp. Hot IP
Related News
- eYs3D Microelectronics, Co. Raises $7 Million Series A from Leading Industry Strategic Investors for Vision/AI Chips
- QuickLogic Announces $1.4 Million Incremental Funding Modification for its Strategic Radiation Hardened Program
- QuickLogic Announces $6.575 Million Contract Award for its Strategic Radiation Hardened Program
- QuickLogic Announces $5.26 Million Contract Award
- ZeroPoint Technologies raises EUR 3.2 million in seed funding to reduce energy consumption of data centers by more than 25%
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- Ceva, Inc. Announces First Quarter 2025 Financial Results
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design
![]() |
E-mail This Article | ![]() |
![]() |
Printer-Friendly Page |